Features
InBrief
Second Opinion
Contributors
About
Jonathan Finlay, MB, ChB, FRCP
The Evolution of Precision Medicine for Children With Aggressive Brain Tumors
The Head Start 4 clinical trial introduces risk stratification and builds on the success of bone marrow transplantation for young children with malignant embryonal tumors.
September 26, 2017 | Written by
Jonathan Finlay, MB, ChB, FRCP
Hematology/Oncology/BMT
,
Neuro-Oncology